REQUEST A DEMO
Total
USD $0.00
Search more companies

Norsa Pharma Sp. z o.o. (Poland)

Main Activities: All Other Food Manufacturing
Secondary Activities: All Other Miscellaneous Food Manufacturing | Pharmaceutical Preparation Manufacturing | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Marketing Research and Public Opinion Polling | All Other Professional, Scientific, and Technical Services
Full name: Norsa Pharma Sp. z o.o. Profile Updated: May 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Norsa Pharma Sp. z o.o is a company specializing in the development, production, and distribution of foods of special purpose, dietary supplements, and medical products. The company focuses on providing solutions for people with rare, metabolic, autoimmune, and eliminatory diseases. Norsa Pharma's products include Puromalt, Cystisorb, and a complex preparation for people with mucoviscidosis and cholestasis. They also offer innovative forms of products to ensure optimal product composition, effective dosing, increased biodisponibility, stability, and the most friendly way of administration. The company operates with a team of experts and collaboration with the scientific environment.

Headquarters
Ul. Prof. Michala Zyczkowskiego 14
Krakow; Malopolskie; Postal Code: 31-864

Contact Details: Purchase the Norsa Pharma Sp. z o.o. report to view the information.

Website: http://www.norsapharma.eu

Basic Information
Total Employees:
Purchase the Norsa Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Norsa Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Norsa Pharma Sp. z o.o. report to view the information.
Incorporation Date:
January 26, 2015
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
44%
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
22.67%
Company Performance
Financial values in the chart are available after Norsa Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
68.69%
Total operating revenue
63.38%
Operating profit (EBIT)
168.89%
EBITDA
111.8%
Net Profit (Loss) for the Period
171.11%
Total assets
40.24%
Total equity
67.94%
Operating Profit Margin (ROS)
12.44%
Net Profit Margin
11.57%
Return on Equity (ROE)
17.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?